Cite
HARVARD Citation
Chuang, W. et al. (2018). Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients. Alimentary pharmacology & therapeutics. 47 (9), pp. 1306-1316. [Online].